Epidemiology of major depressive disorder in Iran: A systematic review and Meta-Analysis

International Journal of Preventive Medicine

Volumn 1, Issue 2, 2010, Pages 81-91

  Sadeghirad, Behnam ^a   Haghdoost, Ali Akbar ^b   Amin Esmaeili, Masoumeh ^c   Shahsavand Ananloo, Esmaeil ^d   Ghaeli, Padideh ^d   Rahimi Movaghar, Afarin ^c   Talebian, Elham ^b   Pourkhandani, Ali ^b   Ali Noorbala, Ahmad ^d   Barooti, Esmat ^e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Depressive disorder; Epidemiology; Mental health; Meta analysis; Prevalence; Review

Indexed keywords

ADOLESCENT; ADULT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; IRAN; MAJOR DEPRESSION; MALE; PREVALENCE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; URBAN RURAL DIFFERENCE;

EID: 79952057856     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-92.
2. Meyer C. Depressive disorders were the fourth leading cause of global disease burden in the year 2000. Evid Based Ment Health 2004; 7(4): 123.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349(9064): 1498-504.
4. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3(11): e442.
5. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002; 72(3): 227-36.
6. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293-9.
7. Alhasnawi S, Sadik S, Rasheed M, Baban A, Al Alak MM, Othman AY, et al. The prevalence and correlates of DSM-IV disorders in the Iraq Mental Health Survey (IMHS). World Psychiatry 2009; 8(2): 97-109.
8. Bromet EJ, Gluzman SF, Paniotto VI, Webb CP, Tintle NL, Zakhozha V, et al. Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol 2005; 40(9): 681-90.
9. Lee S, Tsang A, Zhang MY, Huang YQ, He YL, Liu ZR, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med 2007; 37(1): 61-71.
10. Gureje O, Lasebikan VO, Kola L, Makanjuola VA. Lifetime and 12-month prevalence of mental disorders in the nigerian survey of mental health and well-being. Br J Psychiatry 2006; 188: 465-71.
11. Haro JM, Palacin C, Vilagut G, Martinez M, Bernal M, Luque I, et al. Prevalence of mental disorders and associated factors: results from the ESEMeDSpain study. Med Clin (Barc) 2006; 126(12): 445-51.
12. Tsuchiya M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Tachimori H, et al. Lifetime comorbidities between phobic disorders and major depression in Japan: results from the World Mental Health Japan 2002-2004 Survey. Depress Anxiety 2009; 26(10): 949-55.
13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289(23): 3095-105.
14. Shen YC, Zhang MY, Huang YQ, He YL, Liu ZR, Cheng H, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med 2006; 36(2): 257-67.
15. Kawakami N, Takeshima T, Ono Y, Uda H, Hata Y, Nakane Y, et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci 2005; 59(4): 441-52.
16. Wells JE, Browne MA, Scott KM, McGee MA, Baxter J, Kokaua J. Prevalence, interference with life and severity of 12 month DSM-IV disorders in Te Rau Hinengaro: the New Zealand mental health survey. Aust N Z J Psychiatry 2006; 40(10): 845-54.
17. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, Fleiz C, et al. Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychol Med 2005; 35(12): 1773-83.
18. Haghdoost AA, Sadeghirad B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med 2008; 11(4): 444-52.
19. Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, et al. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemiol Ment Health 2005; 1: 16.
20. Noorbala AA, Bagheri Yazdi SA, Yasamy MT, Mohammad K. Mental health survey of the adult population in Iran. Br J Psychiatry 2004; 184: 70-3.
21. Farhoudian A, Amini H, Sharifi V, Basirnia A, Mesgarpour B, Mansouri N, et al. Prevalence of psychiatric disorders in Iran: A systematic review. Iranian Journal of Psychiatry 2007; 2(4): 137-49.
22. Mohammadi MR, Ghanizadeh A, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, et al. Prevalence of mood disorders in Iran. Iranian Journal of Psychiatry 2006; 1(2): 59-64.
23. Modabernia MJ, Tehrani HS, Fallahi M, Shirazi M, Modabbernia AH. Prevalence of depressive disorders in Rasht, Iran: a community based study. Clin Pract Epidemiol Ment Health 2008; 4: 20.
24. Sadeghi KH, Saberi M, Osareh M. Epidemiology of mental illness in the urban population of Kermanshah. Iranian journal of psychaitry and clinical psychology 2000; 6(22-23): 16-25.
25. Hassanshahi MM, Goodarzi MA, Mirjafari SA, Farnam A. Prevalence of psychiatric disorders in the city Arsanjan. The Quarterly Journal of Fundamentals of Mental Health 2004; 6(21-22): 67-83.
26. Hosseinifard SM, Birashk B, Atef-vahid M. Epidemiology of mental disorders in high-school students in Rafsanjan. Iranian Journal of Psychiatry & Clinical Psychology 2005; 11(1): 71-80.
27. Omidi A, Tabatabaei A. Epidemiology of mental disorders in urbanized areas of Natanz. Iranian Journal of Psychiatry & Clinical Psycholog 2003; 8(4): 32-8.
28. Kaviani H, Ahmadi-Abhari SA, Nazari H, Hormozi K. Prevalence of depressive disorders in Tehran resident population, 2000. Journal of Tehran Faculty of Medicine 2002; 60(5): 393-9.
29. Shamsalizadeh N, Bolhari J, Shahmohammadi D. Epidemiology of mental disorders in a village in Tehran province. Iranian Journal of Psychiatry & Clinical Psychology 2001; 7(1-2): 19-26.
30. Nazari H, Hormozi K, Mashayekhi F, Valizadeh M, Falahati F. Prevalence of depression in Tehran. Yafteh 2002; 3(11): 23-7.
31. Fakhari A, Dadashzadeh H, Ranjbar F. The prevalence of psychiatric disorders in the North West of Tabriz. Medical Journal of Tabriz University of Medical Sciences & Health Services 2003; 25(3): 100-5.
32. Mohammadi A. The epidemiology of mental disorders among high school students of Shahinshahr[Thesis]. Tehran: Iran University of Medical Sciences; 2001.
33. Noorbala AA, Mohammad K, Bagheri Yazdi SA. Prevalence of psychiatric disorders in Tehran city. Hakim Research Journal 1999; 2(4): 212-23.
34. Hassanzadeh G, Meshkini MA. The prevalence of psychiatric disorders in Oskou district. [Thesis]. Tabriz: Tabriz University of Medical Sciences; 1999.
35. Sadeghi K, Saberi SM, Assareh M. Epidemiological study of psychiatric disorders in Kermanshah urban residents. Iranian Journal of Psychiatry & Clinical Psychology 2000; 6(2-3): 16-25.
36. Hosseini SR. The prevalence of mental disorders among 15-25 year-old Youth in rural areas of Taleghan, Tehran. [Thesis]. Tehran: Iran University of Medical Sciences;1996.
37. Ghassemi GR, Asadollahi GA, Ahmadzadeh GH, Najmi B, Palahang H. Prevalence of mental disorders in Isfahan city, 1996. Journal of Research in Medical Sciences 2000; 4(4): 190-4.
38. Yaghoubi N, Nasr M, Shah Mohammadi D. Epidemiology of mental disorders in urban and rural areas of Sowmaesara, Guilan. Iranian Journal of Psychiatry& Clinical Psychology 1995; 2(4): 55-65.
39. Attari A, Ekramnia F, Naghdi F, Farzaneh H, Rismanchian A, Jaberi P. Epidemiological study of the prevalence of depression in people over 20 years in Esfahan. Journal of Research in Medical Sciences 1998; 1(3):41-4.
40. Palahang H, Nasr M, Barahani MN, Shah Mohammadi D. Epidemiology of mental illnesses in Kashan city. Iranian Journal of Psychiatry & Clinical Psychology 1996; 8(2): 19-27.
41. Hosseini SR. Epidemiology of mental disorders among over 15 years old population in rural and urban area of Borujen, 1994. [Thesis]. Tehran: Iran University of Medical Sciences. 1996.
42. Bahadorkhan J. The epidemiology of mental disorders in rural areas of Gonabad.[Thesis].Tehran: Iran University of Medical Sciences. 1998.
43. Javidi H. The epidemiology of mental disorders in rural areas in Marvdasht, Fars province.[Thesis]. Tehran: Iran University of Medical Sciences. 1993.
44. Kokabeh F. The epidemiology of mental disorders in rural areas of Azarshahr-Tabriz province [Thesis] Tehran: Iran University of Medical Sciences. 1993.
45. Bagheri Yazdi A. An epidemiological study of psychological disorders in a rural area (Meibod, Yazd) in Iran. Iranian Journal of Psychiatry & Clinical Psychology 1994; 1(1): 32-41.
46. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol 2007; 63(4): 387-93.
47. Patten SB. Recall bias and major depression lifetime prevalence. Soc Psychiatry Psychiatr Epidemiol 2003; 38(6): 290-6.
48. Berlin JA. Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies. Am J Epidemiol 1995; 142(4): 383-7.
49. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995; 142(4): 371-82.
50. Kessler RC, Walters EE. Epidemiology of DSM-IIIR major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998; 7(1): 3-14.
51. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12- month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51(1): 8-19.
52. Nolen-Hoeksema S, Hilt ML. Gender differences in depression. In: Gotlib LH, Hammen CL, editors. Handbook of depression. New York: Guilford Press; 2002: 492-509.
53. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003; 74(1): 5-13.
54. Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med 1998; 28(1): 51-61.
55. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 2003; 74(1): 67-83.
56. Nolen-Hoeksema S, Jackson B. Mediators of the Gender Difference in Rumination. Psychology of Women Quarterly 2003; 25(1): 37-47.
57. Nolen-Hoeksema S, Larson J, Grayson C. Explaining the gender difference in depressive symptoms. J Pers Soc Psychol 1999; 77(5): 1061-72.
58. Ma X, Xiang YT, Cai ZJ, Li SR, Xiang YQ, Guo HL, et al. Prevalence and socio-demographic correlates of major depressive episode in rural and urban areas of Beijing, China. J Affect Disord 2009; 115(3): 323-30.
59. Sundquist K, Frank G, Sundquist J. Urbanisation and incidence of psychosis and depression: followup study of 4.4 million women and men in Sweden. Br J Psychiatry 2004; 184: 293-8.
60. Wang JL. Rural-urban differences in the prevalence of major depression and associated impairment. Soc Psychiatry Psychiatr Epidemiol 2004; 39(1): 19-25.
61. Rahimi-Movaghar A, Razaghi EM, Haghdoost AA, Saberi Zafarghandy MB, Bashti S, Mirzazadeh A. The Geographical Distribution of Psychosocial Disorders, Resources and Services in Iran, year 2005. Tehran: Ministry of Health; 2008.